Background & aims The incidence of inflammatory bowel disease (IBD) is increasing
internationally, particularly in nations with historically low rates. Previous reports of the …

Inflammatory bowel disease (IBD) is a global disease; its evolution can be stratified into four
epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence …

Microbe–host communication is essential to maintain vital functions of a healthy host, and its
disruption has been associated with several diseases, including Crohn's disease and …

Background Inflammatory bowel disease is a global disease in the 21st century. We aimed
to assess the changing incidence and prevalence of inflammatory bowel disease around the …

Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown aetiology
affecting the colon and rectum. Multiple factors, such as genetic background, environmental …

Background & Aims Inflammatory bowel diseases (IBDs) exist worldwide, with high
prevalence in North America. IBD is complex and costly, and its increasing prevalence …

The inflammatory bowel diseases ulcerative colitis and Crohn's disease are chronic,
relapsing disorders of the gastrointestinal tract. Collectively, these conditions can result in …

Over 1 million residents in the USA and 2.5 million in Europe are estimated to have IBD, with
substantial costs for health care. These estimates do not factor in the'real'price of IBD, which …

IBD, comprising Crohn's disease and ulcerative colitis, is a chronic immunologically
mediated disease at the intersection of complex interactions between genetics, environment …

Crohn's disease and ulcerative colitis have emerged as global diseases. They affect over 2
million individuals in the North America, 3.2 million in Europe, and millions more worldwide …